Pregabalin in the Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy (LSG).

• Status: Not yet recruiting
• Trial end date: 2025-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this clinical trial is to assess preemptive oral pregabalin administration in the obese patients undergoing laparoscopic sleeve gastrectomy. The main aims of the study are to evaluate postoperative pain treatment and effect on the intraoperative hemodynamical stability.

Participants will be divided into 2 groups: with or without preemptive pregabalin administration.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of Warsaw
• Treatments: Pregabalin

Criteria

Inclusion Criteria:

• Sleeve gastrectomy in patients with BMI > 40 or >35 with comorbidities

• Written informed consent

Exclusion Criteria:

• Patient's refusal

• Known allergies to study medication

• Inability to comprehend or participate In pain scoring scale

• Inability to use intravenous patient controlled analgesia

• Changes of operation extent during procedure

• Revisional operations

• End stage organ failure